|
Summary Information: 9 Meters Biopharma Inc. Common Stock NASDAQ:NMTR |
  admin@troach.net |
Our Main Pages Stocks.TRoach.Net TRoach.Org TRoach.Net |
_Description: 9 Meters Biopharma, Inc. ('the Company') is a rare and unmet needs-focused gastroenterology company. The Company is advancing NM-002, a proprietary long-acting GLP-1 agonist into a Phase 2 trial for short bowel syndrome (SBS), a rare, orphan disease, as well as larazotide, a Phase 3 tight junction regulator being evaluated for patient-reported symptom improvement in non-responsive celiac disease.
__The following are links to various summary and news pages for __9 Meters Biopharma Inc. Common Stock [ NMTR ]. __Note: Some Links might not have information for the company. |
|